NephroGenex Announces Data on Acute Kidney Injury at National Kidney Foundation 2015 Spring Clinical Meetings.Pyridorin is a novel compound shown to target and reduce pathogenic oxidative chemistries that emerge in kidney disease. Oral Pyridorin is being evaluated in a pivotal Phase 3 program in diabetic nephropathy.
URL:
www.businesswire.com/news/home/20150327005047/en/NephroGenex-Announces-Data-Acute-Kidney-Injury-National#.VRVM9VSUc8o
URL:
www.businesswire.com/news/home/20150327005047/en/NephroGenex-Announces-Data-Acute-Kidney-Injury-National#.VRVM9VSUc8o
No comments:
Post a Comment